|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 413/14 | (2006.01) |
| C07D 413/12 | (2006.01) | ||
| C07D 417/14 | (2006.01) | ||
| A61K 31/42 | (2006.01) | ||
| A61P 7/00 | (2006.01) |
| (11) | Number of the document | 1526132 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04027037.3 |
| Date of filing the European patent application | 2000-12-11 | |
| (97) | Date of publication of the European application | 2005-04-27 |
| (45) | Date of publication and mention of the grant of the patent | 2014-03-12 |
| (46) | Date of publication of the claims translation | 2014-07-25 |
| (30) | Number | Date | Country code |
| 19962924 | 1999-12-24 | DE |
| (72) |
Straub, Alexander, Dr., DE
Lampe, Thomas, Dr., DE
Pohlmann, Jens, Dr., CH
Röhrig, Susanne, Dr., DE
Perzborn, Elisabeth, Dr., DE
Schlemmer, Karl-Heinz, Dr., DE
Pernerstorfer, Joseph, Dr., DE
|
| (73) |
Bayer Intellectual Property GmbH,
Alfred-Nobel-Strasse 10, 40789 Monheim,
DE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Pakeistieji oksazolidinono dariniai ir jų panaudojimas kaip Xa faktoriaus slopiklių |
| Substituted oxazolidinone derivatives and their use as factor xa inhibitors |
| Payment date | Validity (years) | Amount | |
| 2019-12-04 | 20 | 347.00 EUR |